PID1 and glioblastoma: In the current experiments, we set about to examine the regulatory effects that IGF2BP2 on GBM cell chemoresistance and analyze the potential regulatory network of the IGF2BP2/DANCR/FOXO1/PID1, aiming to provide a novel antitumor target for tumor treatment.